Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in Genpact Limited $G

Sumitomo Mitsui Trust Group Inc. grew its position in shares of Genpact Limited (NYSE:GFree Report) by 3.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 2,584,606 shares of the business services provider’s stock after acquiring an additional 82,918 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Genpact were worth $108,269,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of G. LSV Asset Management purchased a new stake in Genpact during the second quarter valued at $71,592,000. Norges Bank bought a new stake in shares of Genpact in the 2nd quarter worth about $52,819,000. Invesco Ltd. increased its holdings in shares of Genpact by 334.9% in the 2nd quarter. Invesco Ltd. now owns 1,403,292 shares of the business services provider’s stock worth $61,759,000 after buying an additional 1,080,602 shares during the last quarter. Nordea Investment Management AB raised its position in shares of Genpact by 60.2% during the 2nd quarter. Nordea Investment Management AB now owns 2,617,255 shares of the business services provider’s stock valued at $114,924,000 after buying an additional 983,774 shares in the last quarter. Finally, Jupiter Asset Management Ltd. lifted its holdings in shares of Genpact by 601.5% in the 2nd quarter. Jupiter Asset Management Ltd. now owns 1,081,109 shares of the business services provider’s stock valued at $47,580,000 after acquiring an additional 927,003 shares during the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.

Genpact Trading Down 1.2%

Shares of NYSE G opened at $46.55 on Wednesday. Genpact Limited has a fifty-two week low of $37.49 and a fifty-two week high of $56.76. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.51 and a current ratio of 1.51. The company has a market cap of $8.03 billion, a price-to-earnings ratio of 15.02, a PEG ratio of 1.40 and a beta of 0.75. The business’s 50 day moving average price is $45.82 and its 200-day moving average price is $43.89.

Genpact (NYSE:GGet Free Report) last announced its quarterly earnings data on Thursday, November 6th. The business services provider reported $0.97 EPS for the quarter, beating the consensus estimate of $0.90 by $0.07. Genpact had a return on equity of 22.55% and a net margin of 11.01%.The company had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the prior year, the company posted $0.85 EPS. Genpact’s quarterly revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.600-3.610 EPS and its Q4 2025 guidance at 0.930-0.940 EPS. On average, sell-side analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have weighed in on G. Wall Street Zen raised Genpact from a “hold” rating to a “buy” rating in a research note on Saturday. Citigroup raised Genpact to a “hold” rating in a research report on Thursday, October 23rd. Susquehanna assumed coverage on Genpact in a research report on Friday, December 12th. They issued a “neutral” rating and a $50.00 price target for the company. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Genpact in a research note on Friday, December 26th. Three equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $51.00.

View Our Latest Research Report on G

Insider Transactions at Genpact

In other Genpact news, SVP Riju Vashisht sold 16,016 shares of the company’s stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $46.65, for a total value of $747,146.40. Following the transaction, the senior vice president directly owned 95,521 shares in the company, valued at $4,456,054.65. This represents a 14.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Tamara Franklin sold 2,750 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $45.65, for a total transaction of $125,537.50. Following the transaction, the director directly owned 22,236 shares in the company, valued at approximately $1,015,073.40. This trade represents a 11.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 60,385 shares of company stock worth $2,762,475. Insiders own 2.80% of the company’s stock.

Genpact Company Profile

(Free Report)

Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.

Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.

Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.

Featured Stories

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.